JX-929

AXP000097.1 · Oncolytic virus

Platform
vaccinia virus (Western Reserve, TK- VGF-)
Originator
University of Pittsburgh (David Bartlett)
Sponsor
Jennerex Biotherapeutics

Names

NameTypeSource
JX-929preferred name, codecurator, curator
vvDD-CDSRcodencit
vvDD ambiguoussynonymctgov

Virus

Role
Oncolytic
Family
Poxviridae
Virus
vaccinia virus (NCBI Taxonomy 10245)
Strain
Western Reserve
Replication
conditionally replicating
Modifications
J2R (thymidine kinase) and C11R (vaccinia growth factor) both deleted
Transgenes
cytosine deaminase, SSTR2
Route
intratumoral, intravenous
Source
evidence

Cross-references

NCI Thesaurus
C74089

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT00574977Safety Study of Modified Vaccinia Virus to CancerCompletedPhase 12008-052013-0126Breast Cancer; Colorectal Cancer; Head and Neck Squamous Cell Cancer; Liver Cancer; Melanoma; Pancreatic Adenocarcinoma
Unconfirmed matches (1)

Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditionsMatched by
NCT07001592Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal TumorsRecruitingPhase 12025-05-062028-0418Esophageal Cancer; Gastric Adenocarcinoma; Gastric Cancer; Gastric Neoplasms; Liver Cancer; Liver Metastasis; MSI-H; MSS; MSS-CRC; Peritoneal Cancer; Peritoneal Carcinoma; Peritoneal Metastasesname in intervention: vvDD

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Unconfirmed matches (1)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 27203445Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.Molecular therapy : the journal of the American Society of Gene Therapy2016name in title: vvDD

Notes

The 'double-deleted' vaccinia vvDD armed with cytosine deaminase and the somatostatin receptor; phase 1 by intratumoral and intravenous injection (NCT00574977). The unarmed vvDD backbone is a platform, not a separate program here. A cell-carrier form (autologous CIK cells loaded with vvDD-CDSR, CRX100, NCIt C179187) is a different product and is not entered.

How to cite

JX-929 (AXP000097.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000097.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.